Publications by authors named "D Califano"

Claim this Profile
C
CCDC6 immunostaining in conjunction with the Rad51 HRD assay may expand PARPi treatment eligibility in HGSOC patients.
Daniela Criscuolo, Francesco Merolla, Benedetta Pellegrino, Luca Russolillo, Ilaria De Benedictis, Daniela Califano

Cancer Res Commun· December 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Homologous recombination repair status in advanced endometrial cancer: an exploratory biomarker analysis from the randomized, phase II MITOEND 3 trial.
M Bartoletti, A Passarelli, A Fagotti, C Andreetta, S Tamberi, D Califano

ESMO Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The immunotherapy era in ovarian clear cell carcinoma: current evidence and future perspective.
Anna Passarelli, Sabrina Chiara Cecere, Jole Ventriglia, Carmela Pisano, Rosella De Cecio, Daniela Califano

Front Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour-infiltrating leucocytes as prognostic biomarkers of bevacizumab-treated ovarian cancer patients results from the phase IV MITO16A/MaNGO OV-2 clinical trial.
Eliana Pivetta, Vincenzo Canzonieri, Marina Bagnoli, Paolo Chiodini, Anna Spina, Daniela Califano

NPJ Precis Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exceptional Response to Trastuzumab Deruxtecan (T-DXd) in HER2-Positive Metastatic Endometrial Cancer.
Riccardo Vida, Michele Bartoletti, Lucia Lerda, Serena Corsetti, Simona Scalone, Daniela Califano

Curr Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis